Physician profile
Amber E Angles
NPI 1407205966
$2,676.07
in general payments reported to CMS, 2019-2025
21 companies · $724 in 2025
The $724 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $72.42 · 2021: $214 · 2022: $175 · 2023: $666 · 2024: $825 · 2025: $724.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,124 · Education: $90.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,124.20 |
| Education | $90.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $619.30 | 2021-2025 | Ubrelvy, Vraylar, Qulipta |
| Glaxosmithkline, LLC. | $510.54 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astellas Pharma US INC | $358.25 | 2023-2025 | Veozah, Myrbetriq |
| Astrazeneca Pharmaceuticals Lp | $326.25 | 2020-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $196.68 | 2020-2025 | |
| Lilly USA, LLC | $176.90 | 2023-2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $91.77 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Edwards Lifesciences Corporation | $77.89 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Amgen INC. | $58.80 | 2024-2025 | Evenity, Otezla, Repatha |
| Otsuka America Pharmaceutical, INC. | $41.75 | 2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $33.56 | 2021-2022 | |
| Organogenesis INC. | $25.19 | 2024 | |
| Aimmune Therapeutics, INC. | $24.08 | 2025 | Zenpep |
| Xeris Pharmaceuticals, INC. | $19.46 | 2023 | Gvoke Hypopen |
| Novo Nordisk INC | $18.60 | 2024 | Rybelsus, Ozempic |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $18.20 | 2020 | |
| Horizon Therapeutics Plc | $17.54 | 2021 | |
| Nestle Healthcare Nutrition INC. | $17.31 | 2021 | |
| Axsome Therapeutics, INC. | $15.53 | 2025 | Auvelity |
| Bayer Healthcare Pharmaceuticals INC. | $15.02 | 2020 | |
| Medtronic, INC. | $13.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Angles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.